(PharmaNewsWire.Com, April 13, 2022 ) The Biochemistry Analyser Market is bound to reach US$ 4,625.3 Mn at a CAGR of 5.5% between 2016-2024. The current scenario is such that on-demand healthcare storage is being asked for. Cloud computing thus curtails operational expenses and capital as it simplifies sharing medical records, creates and maintains telehealth apps, and automates backend operations. This would be the scene with the healthcare vertical in the upcoming period.
The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. In addition to this, the accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe.
Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors. A recent report published by Persistence Market Research projects that by the end of 2027, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.
Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction. The report current values the global biochemistry analyzer market at a little over US$ 3,000 Mn.
During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.
Company Profiles:
Roche Diagnostics GmbH Siemens AG Beckman Coulter Inc. Abbott Diagnostics Inc. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Hologic, Inc. Randox Laboratories Ltd. Awareness Technology, Inc. Transasia Biomedicals Ltd Nova Biomedical Corp. Others
The global market for biochemistry analyzers represents an absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and an incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024 Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patients’ metabolic functions.
Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR.
Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers – a cost-effective upgrade to existing product line The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come.
In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers.
Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR.
The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together,hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.
How About Knowing The Product/Technology Driving The Biochemistry Analyzer Market Before Investing Therein? Click The “Purchase Now” Button Of Our Biochemistry Analyzer Market Report! https://www.persistencemarketresearch.com/checkout/6451
The use of biochemistry analyzers in drug development applications is also expected to gain traction in the future. Based on modality, the report forecasts that in 2016, more than 70% of the market value was accounted by bench-top biochemistry analyzers.
However, towards the end of the forecast period, the demand for bench-top modality will incur a marginal decline, while floor standing biochemistry analyzers will bring in over US$ 1,200 Mn revenues.
Access Related Reports-
E Clinical Solution Market The global e-clinical solution software market is estimated to surpass USD 6,515 Mn by 2020, expanding at 13.8% CAGR with healthy revenue, valuation, trends & forecast.
E-Prescribing Market The global E-Prescribing market was valued at USD 250.2 million in 2013 and is expected to grow at a CAGR of 23.5% from 2013 to 2019, to reach an estimated value of USD 887.8 million in 2019.
Care Management Solutions Market The global care management solutions market is set to be valued at over US$ 18.5 Bn in 2022 and surge at a CAGR of 17.4% to close in on a valuation of US$ 66.9 Bn by the year 2030.
Smart Pills Market As per PMR's study report, the global smart pills market will reflect a splendid expansion through the forecast period (2017-2026) with revenues worth US$ 3,000 Mn by 2026-end.
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us:
Persistence Market Research Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States U.S. Ph. – +1-646-568-7751 USA-Canada Toll-free – +1 800-961-0353 Sales – sales@persistencemarketresearch.com Website – https://www.persistencemarketresearch.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
